Despite gains, Nasdaq faced higher operating expenses, primarily due to acquisition-related costs. The increased expenses were efficiently managed, reporting Q4 GAAP operating income rose by 47%.

For the quarter ended December 2024, Nasdaq (NDAQ) reported revenue of $1.23 billion, up 9.9% over the same period last year. EPS came in at $0.76, compared to $0.72 in the year-ago quarter.

Nasdaq (NDAQ) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.72 per share a year ago. These figures ...

Nasdaq, Inc. NDAQ reported fourth-quarter 2024 adjusted earnings per share of 76 cents, beating the Zacks Consensus Estimate by 1.3%. The bottom line improved 5% year over year. The improvement ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Q4 2024 Earnings Call Transcript February 6, 2025 Monolithic Power Systems, Inc. beats earnings expectations. Reported EPS is ...

EPS: $1.48 in Q4 vs. -$0.48 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...

Snap-on Incorporated SNA prepares to announce its fourth-quarter 2024 earnings results on Feb. 6, before the opening bell. The Zacks Consensus Estimate for revenues is $1.2 billion, which ...

It is expected to announce its fiscal Q4 earnings results on Thursday ... of the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's financial ...

PepsiCo (PEP) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.78 per share a year ago. These figures ...

Meta stock (NASDAQ: META) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. It reported sales of $48.4 billion and earnings of $8.02 per share ...

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in ...